HSV-2 IgG Antibodies
HSV-2 IgG antibodies are produced by the immune system in response to Herpes Simplex Virus type 2, which is most commonly linked to genital herpes. A positive result indicates prior exposure to HSV-2, even if no symptoms have been experienced. These antibodies usually develop within several weeks after infection and persist long-term. The test identifies whether an individual has been infected at some point but cannot determine the timing or whether the virus is currently active.
Description
Testing for HSV-2 IgG antibodies is recommended for individuals with recurrent genital symptoms, those with new sexual partners, or during pregnancy to assess transmission risk. It’s also relevant for people undergoing IVF or immunosuppressive therapy, where latent infections can affect outcomes.
- Painful genital sores or blisters
- Itching or burning in the genital area
- Flu-like symptoms during the first outbreak
- Painful urination
- Swollen lymph nodes
- Nerve pain or discomfort in the pelvic region
HSV-2 is primarily transmitted through sexual contact, including genital-genital, oral-genital, or anal-genital contact. The virus can be spread even when symptoms are not present, through asymptomatic viral shedding.
A positive result means the immune system has developed antibodies against HSV-2, indicating previous infection. It does not reflect current infectivity or activity level, but it confirms that the virus is present in the body and may be intermittently contagious.
